RxDoctor Payments Data

Andrea Zinke

Nurse Practitioner · Eastpointe, MINPI 1346740420

Payments from drug & device makers

$4,347in general payments, 2019–2025

Across 236 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$739
  • Bayer$299
  • Amgen$233
  • Pfizer$228
  • AstraZeneca$216
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,347 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$51,373
JardianceEmpagliflozin27$35,105
EliquisApixaban23$26,709
OzempicSemaglutide21$26,338
MounjaroTirzepatide13$16,912
XareltoRivaroxaban17$13,938
Aimovig AutoinjectorErenumab-Aooe11$7,920
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,644
Albuterol Sulfate HfaAlbuterol Sulfate63$2,435
Klor-ConPotassium Chloride12$1,914
Atorvastatin Calcium127$1,825
Nifedipine ErNifedipine23$1,740
Ventolin HfaAlbuterol Sulfate12$1,529
Estradiol (Twice Weekly)Estradiol12$1,113
Metoprolol Succinate46$1,011

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$156$59,01790 claims
Boehringer IngelheimJardiance$181$35,10527 claims
PfizerEliquis$228$26,70923 claims
Novo NordiskOzempic$1,064$26,33821 claims
Lilly USA, LLCMounjaro$739$16,91213 claims
Johnson & JohnsonXarelto$40$13,93817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Eastpointe

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →